معرفی
Dr. Timo ten Hagen is an Associate Professor in the Department of Pathology at Erasmus MC, part of Erasmus University Rotterdam. His research focuses on cancer therapy, immunology, and nanomedicine, with an emphasis on targeted drug delivery systems and nanoparticle-based treatments. He has contributed to studies on immunoliposomes for cervical cancer, CD81-guided EV interactions in breast cancer, and lipid-based nanosystems for immune therapy. His work integrates molecular pharmacology with clinical applications, aiming to improve therapeutic efficacy and reduce side effects in oncology.
Key areas of research include PD-L1 targeting, nanoparticle design, and catalytic imaging for theranostic applications. He has supervised 15 academic works, though student names are not specified here. Collaborations span interdisciplinary teams in Europe, addressing challenges in tumor biology and drug delivery mechanisms. His research outputs include peer-reviewed articles in journals like Journal of Controlled Release and Journal of Hematology and Oncology.
Notable contributions involve dynamic in vitro models (e.g., cancer-on-a-chip) and systematic reviews on HPV viral load correlations with cervical disease severity. His work bridges basic science and clinical translation, emphasizing nanotechnology’s role in advancing oncology care.
